Marvel Biosciences awards 50,001 deferred share units to independent directors
Marvel Biosciences Corp. (and its wholly owned subsidiary) announced the award of 50,001 deferred share units (DSUs) to its three independent directors.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.